Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [923]
News [2690]
Articles [121]
Editorials [3]
Conferences [86]
elearning [27]
SPLENDOUR: Added denosumab in first line adv NSCLC treatment
Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne...
SPLENDOUR: Added denosumab in first line adv NSCLC treatment ( Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
22 Oct 2018
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy
Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
Advances in metastatic non small cell lung cancer
Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
21 Oct 2018
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC
Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC ( Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA )
21 Oct 2018
A novel bifunctional fusion protein for combatting lung cancer
Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain
A novel bifunctional fusion protein for combatting lung cancer ( Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain )
21 Oct 2018
Societal indicators of lung cancer screening behaviours
Prof Jean-François Morère - Hôpital Paul Brousse, Villejuif, France
Societal indicators of lung cancer screening behaviours ( Prof Jean-François Morère - Hôpital Paul Brousse, Villejuif, France )
20 Oct 2018
Rare EGFR mutations in lung adenocarcinoma
Prof Nicolas Girard - Institut Curie, Paris, France
Rare EGFR mutations in lung adenocarcinoma ( Prof Nicolas Girard - Institut Curie, Paris, France )
20 Oct 2018
The microbiome – a novel paradigm in oncology research
Dr Alasdair Scott - Imperial College London, London, UK
The microbiome – a novel paradigm in oncology research ( Dr Alasdair Scott - Imperial College London, London, UK )
5 Sep 2018
New important compounds for targeted and immunotherapies for lung cancer
Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA
New important compounds for targeted and immunotherapies for lung cancer ( Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA )
7 Aug 2018
Updates from a range of lung cancer studies
Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA
Updates from a range of lung cancer studies ( Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA )
7 Aug 2018
Five practice changing shifts in oncology
Dr Jack West - Swedish Cancer Institute, Seattle, USA
Five practice changing shifts in oncology ( Dr Jack West - Swedish Cancer Institute, Seattle, USA )
7 Aug 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation